<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39370682</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>152</Volume><PubDate><Year>2024</Year><Month>Oct</Month><Day>07</Day></PubDate></JournalIssue><Title>Epidemiology and infection</Title><ISOAbbreviation>Epidemiol Infect</ISOAbbreviation></Journal><ArticleTitle>Will COVID-19 become mild, like a cold?</ArticleTitle><Pagination><StartPage>e120</StartPage><MedlinePgn>e120</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e120</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1017/S0950268824001110</ELocationID><Abstract><AbstractText>Several recent studies conclude that an increase in the pathogenicity of SARS-CoV-2 cannot be ruled out. However, it should be noted that SARS-CoV-2 is a 'direct' respiratory virus - meaning it is usually spread by the respiratory route but does not routinely pass through the lymphatics like measles and smallpox. Providing its tropism does not change, it will be unique if its pathogenicity does not decrease until it becomes similar to common cold viruses. Ewald noted in the 1980s that respiratory viruses may evolve mildness because their spread benefits from the mobility of their hosts. This review examines factors that usually lower respiratory viruses' severity, including heat sensitivity (which limits replication in the warmer lungs) and changes to the virus's surface proteins. Other factors may, however, increase pathogenicity, such as replication in the lymphatic system and spreading via solid surfaces or faecal matter. Furthermore, human activities and political events could increase the harmfulness of SARS-CoV-2, including the following: large-scale testing, especially when the results are delayed; transmission in settings where people are close together and not free to move around; poor hygiene facilities; and social, political, or cultural influences that encourage sick individuals to remain active, including crises such as wars. If we can avoid these eventualities, SARS-CoV-2 is likely to evolve to be milder, although the timescale is uncertain. Observations of influenza-like pandemics suggest it may take around two decades for COVID-19 to become as mild as seasonal colds.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shaw Stewart</LastName><ForeName>Patrick D</ForeName><Initials>PD</Initials><Identifier Source="ORCID">0000-0002-0184-4083</Identifier><AffiliationInfo><Affiliation>Independent scientist.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Epidemiol Infect</MedlineTA><NlmUniqueID>8703737</NlmUniqueID><ISSNLinking>0950-2688</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Pathogenicity of respiratory viruses</Keyword><Keyword MajorTopicYN="N">incubation periods</Keyword><Keyword MajorTopicYN="N">pathogenicity of COVID-19</Keyword><Keyword MajorTopicYN="N">thermal sensitivity</Keyword><Keyword MajorTopicYN="N">viral evolution</Keyword><Keyword MajorTopicYN="N">virulence</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>1</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39370682</ArticleId><ArticleId IdType="pmc">PMC11488471</ArticleId><ArticleId IdType="doi">10.1017/S0950268824001110</ArticleId><ArticleId IdType="pii">S0950268824001110</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Markov PV, et al. (2023) The evolution of SARS-CoV-2. Nature Reviews Microbiology 21(6), 361–379.</Citation><ArticleIdList><ArticleId IdType="pubmed">37020110</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochman N, Wolf YI, Koonin EV (2021) Evolution of human respiratory virus epidemics. F1000Research, 10, 447. 10.12688/f1000research.53392.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.53392.2</ArticleId><ArticleId IdType="pmc">PMC8381341</ArticleId><ArticleId IdType="pubmed">34484689</ArticleId></ArticleIdList></Reference><Reference><Citation>Roemer C, et al. 2023. SARS-CoV-2 evolution in the Omicron era. Nature Microbiology 8, 1952–1959. 10.1038/s41564-023-01504-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-023-01504-w</ArticleId><ArticleId IdType="pubmed">37845314</ArticleId></ArticleIdList></Reference><Reference><Citation>Bushmaker T, et al. (2023) Comparative aerosol and surface stability of SARS-CoV-2 variants of concern. Emerging Infectious Diseases 29(5), 1033.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10124653</ArticleId><ArticleId IdType="pubmed">37054984</ArticleId></ArticleIdList></Reference><Reference><Citation>Ewald PW (1983) Host-parasite relations, vectors, and the evolution of disease severity. Annual Review of Ecology and Systematics 14(1), 465–485.</Citation></Reference><Reference><Citation>Olszewska W, Zambon M, Openshaw PJ (2002) Development of vaccines against common colds. British Medical Bulletin 62(1), 99–111.</Citation><ArticleIdList><ArticleId IdType="pubmed">12176853</ArticleId></ArticleIdList></Reference><Reference><Citation>Walther BA, Ewald PW (2004) Pathogen survival in the external environment and the evolution of virulence. Biological Reviews 79(4), 849–869.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7161823</ArticleId><ArticleId IdType="pubmed">15682873</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin AT, et al. (2020) Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications. European Journal of Epidemiology 35(12), 1123–1138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7721859</ArticleId><ArticleId IdType="pubmed">33289900</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhingra A, et al. (2019) Molecular evolution of human adenovirus (HAdV) species C. Scientific Reports 9(1), 1039.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6355881</ArticleId><ArticleId IdType="pubmed">30705303</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss WJ, Griffin DE (2012) Measles. Lancet 379(9811), 153–164. doi:10.1016/S0140-6736(10)62352-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)62352-5</ArticleId><ArticleId IdType="pubmed">21855993</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedel DM, Cappell MS (2023) Diarrhea and coronavirus disease 2019 infection. Gastroenterology Clinics 52(1), 59–75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9659511</ArticleId><ArticleId IdType="pubmed">36813431</ArticleId></ArticleIdList></Reference><Reference><Citation>Heijne JC, et al. (2009) Enhanced hygiene measures and norovirus transmission during an outbreak. Emerging Infectious Diseases 15(1), 24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2660689</ArticleId><ArticleId IdType="pubmed">19116045</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CC, et al. (1999) Neurologic complications in children with enterovirus 71 infection. New England Journal of Medicine 341(13), 936–942.</Citation><ArticleIdList><ArticleId IdType="pubmed">10498488</ArticleId></ArticleIdList></Reference><Reference><Citation>European Centre for Disease Prevention and Control (2023) Disease factsheet about poliomyelitis. Available at https://www.ecdc.europa.eu/en/poliomyelitis/facts (accessed 19 January 2024).</Citation></Reference><Reference><Citation>Turner RB (2015) The common cold. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 748–752.e2. doi: 10.1016/B978-1-4557-4801-3.00058-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-1-4557-4801-3.00058-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Sneed RS et al. (2012) Parenthood and host resistance to the common cold. Psychosomatic Medicine 74(6), 567.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3746028</ArticleId><ArticleId IdType="pubmed">22773866</ArticleId></ArticleIdList></Reference><Reference><Citation>du Prel JB, et al. (2009) Are meteorological parameters associated with acute respiratory tract infections? Clinical Infectious Diseases 49(6), 861–868.</Citation><ArticleIdList><ArticleId IdType="pubmed">19663691</ArticleId></ArticleIdList></Reference><Reference><Citation>Ewald PW (1991) Transmission modes and the evolution of virulence: with special reference to cholera, influenza, and AIDS. Human Nature 2(1), 1–30.</Citation><ArticleIdList><ArticleId IdType="pubmed">24222188</ArticleId></ArticleIdList></Reference><Reference><Citation>Macdonald P, Lyth JC (1918) Incubation period of influenza. British Medical Journal 2(3018), 488.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2342083</ArticleId><ArticleId IdType="pubmed">20769243</ArticleId></ArticleIdList></Reference><Reference><Citation>Muchmore HG, et al. (1981) Persistent parainfluenza virus shedding during isolation at the South Pole. Nature 289(5794), 187–189.</Citation><ArticleIdList><ArticleId IdType="pubmed">6256653</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw Stewart PD, Bach JL (2022) Temperature dependent viral tropism: understanding viral seasonality and pathogenicity as applied to the avoidance and treatment of endemic viral respiratory illnesses. Reviews in Medical Virology 32(1), e2241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8209954</ArticleId><ArticleId IdType="pubmed">33942417</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw Stewart PD, Bach JL (2022) The natural thermal sensitivity of SARS-CoV-2. Infectious Medicine 1(3), 227.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9419432</ArticleId><ArticleId IdType="pubmed">38014365</ArticleId></ArticleIdList></Reference><Reference><Citation>Heindl MR, Böttcher-Friebertshäuser E (2023) The role of influenza A virus and coronavirus viral glycoprotein cleavage in host adaptation. Current Opinion in Virology 58, 101303. 10.1016/j.coviro.2023.101303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2023.101303</ArticleId><ArticleId IdType="pmc">PMC9847222</ArticleId><ArticleId IdType="pubmed">36753938</ArticleId></ArticleIdList></Reference><Reference><Citation>Herder V, et al. (2021) Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defenses. PLoS Biology 19(12), e3001065.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8765667</ArticleId><ArticleId IdType="pubmed">34932557</ArticleId></ArticleIdList></Reference><Reference><Citation>Iserman C, et al. (2020) Genomic RNA elements drive phase separation of the SARS-CoV-2 nucleocapsid. Molecular Cell 80(6), 1078–1091. doi:10.1016/j.molcel.2020.11.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.11.041</ArticleId><ArticleId IdType="pmc">PMC7691212</ArticleId><ArticleId IdType="pubmed">33290746</ArticleId></ArticleIdList></Reference><Reference><Citation>Laporte M, et al. (2021) The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways. PLoS Pathogens 17(4), e1009500. doi:10.1371/journal.ppat.1009500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009500</ArticleId><ArticleId IdType="pmc">PMC8061995</ArticleId><ArticleId IdType="pubmed">33886690</ArticleId></ArticleIdList></Reference><Reference><Citation>Prévost J, et al. (2021) Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2. Journal of Biological Chemistry 297(4). doi:10.1016/j.jbc.2021.101151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.101151</ArticleId><ArticleId IdType="pmc">PMC8406544</ArticleId><ArticleId IdType="pubmed">34478710</ArticleId></ArticleIdList></Reference><Reference><Citation>Ewald PW (2011) Evolution of virulence, environmental change, and the threat posed by emerging and chronic diseases. Ecological Research 26, 1017–1026.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7089224</ArticleId><ArticleId IdType="pubmed">32214653</ArticleId></ArticleIdList></Reference><Reference><Citation>Papenburg J, et al. (2010) Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory-confirmed secondary attack rates and evidence of asymptomatic infections. Clinical Infectious Diseases 51(9), 1033–1041.</Citation><ArticleIdList><ArticleId IdType="pubmed">20887206</ArticleId></ArticleIdList></Reference><Reference><Citation>Tandale BV, et al. (2010) Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India. BMC Infectious Diseases 10(1), 1–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2936412</ArticleId><ArticleId IdType="pubmed">20738878</ArticleId></ArticleIdList></Reference><Reference><Citation>Thai PQ, et al. (2014) Pandemic H1N1 virus transmission and shedding dynamics in index case households of a prospective Vietnamese cohort. Journal of Infection 68(6), 581–590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4031397</ArticleId><ArticleId IdType="pubmed">24491598</ArticleId></ArticleIdList></Reference><Reference><Citation>Foy HM, et al. (1987) Influenza B in households: virus shedding without symptoms or antibody response. American Journal of Epidemiology 126(3), 506–515.</Citation><ArticleIdList><ArticleId IdType="pubmed">3303918</ArticleId></ArticleIdList></Reference><Reference><Citation>Granados A, et al. (2015) Comparison of asymptomatic and symptomatic rhinovirus infections in university students: incidence, species diversity, and viral load. Diagnostic Microbiology and Infectious Disease 82(4), 292–296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7127333</ArticleId><ArticleId IdType="pubmed">25999242</ArticleId></ArticleIdList></Reference><Reference><Citation>Galanti M, et al. (2019) Rates of asymptomatic respiratory virus infection across age groups. Epidemiology &amp; Infection 147, e176. 10.1017/S0950268819000505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268819000505</ArticleId><ArticleId IdType="pmc">PMC6518513</ArticleId><ArticleId IdType="pubmed">31063096</ArticleId></ArticleIdList></Reference><Reference><Citation>Lwoff A (1959) Factors influencing the evolution of viral diseases at the cellular level and in the organism. Bacteriological Review 23(3), 109–124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC181026</ArticleId><ArticleId IdType="pubmed">14419105</ArticleId></ArticleIdList></Reference><Reference><Citation>Benlarbi, M., et al. Temperature-dependent Spike-ACE2 interaction of Omicron subvariants is associated with viral transmission. m Bio 15, e00907-24. 10.1128/mbio.00907-24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.00907-24</ArticleId><ArticleId IdType="pmc">PMC11323525</ArticleId><ArticleId IdType="pubmed">38953636</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong SY, et al. (2022) Temperature influences the interaction between SARS-CoV-2 spike from omicron subvariants and Human ACE2. Viruses 14(10), 2178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9607596</ArticleId><ArticleId IdType="pubmed">36298733</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw Stewart PD (2016). Seasonality and selective trends in viral acute respiratory tract infections. Medical Hypotheses 86, 104–119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116927</ArticleId><ArticleId IdType="pubmed">26608252</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiemken TL, et al. (2023) Seasonal trends in COVID-19 cases, hospitalizations, and mortality in the United States and Europe. Scientific Reports 13(1), 3886.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9994397</ArticleId><ArticleId IdType="pubmed">36890264</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Zhao S (2021) Furin cleavage sites naturally occur in coronaviruses. Stem Cell Research 50, 102115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836551</ArticleId><ArticleId IdType="pubmed">33340798</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson BA, et al. (2021) Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis. Nature 591(7849), 293–299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8175039</ArticleId><ArticleId IdType="pubmed">33494095</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith GJ, et al. (2009) Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459(7250), 1122–1125.</Citation><ArticleIdList><ArticleId IdType="pubmed">19516283</ArticleId></ArticleIdList></Reference><Reference><Citation>Imperiale MJ, Howard D, Casadevall A (2018) The Silver Lining in Gain-of-Function Experiments with Pathogens of Pandemic Potential. In Yamauchi Y (ed.), Influenza Virus. Methods in Molecular Biology, vol 1836, New York, NY: Humana Press. 10.1007/978-1-4939-8678-1_28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-8678-1_28</ArticleId><ArticleId IdType="pmc">PMC7120448</ArticleId><ArticleId IdType="pubmed">30151593</ArticleId></ArticleIdList></Reference><Reference><Citation>Segreto R, Deigin Y (2021) The genetic structure of SARS-CoV-2 does not rule out a laboratory origin: SARS-COV-2 chimeric structure and furin cleavage site might be the result of genetic manipulation. Bioessays 43(3), 2000240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7744920</ArticleId><ArticleId IdType="pubmed">33200842</ArticleId></ArticleIdList></Reference><Reference><Citation>Badgett MR, et al. (2002) Evolutionary dynamics of viral attenuation. Journal of Virology 76(20), 10524–10529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC136581</ArticleId><ArticleId IdType="pubmed">12239331</ArticleId></ArticleIdList></Reference><Reference><Citation>Houlihan C, Behrens R (2017) Lassa fever. BMJ 358, j2986. 10.1136/bmj.j2986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.j2986</ArticleId><ArticleId IdType="pubmed">28701331</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeder M, et al. (2023) An extended period of elevated influenza mortality risk follows the main waves of influenza pandemics. Social Science &amp; Medicine 328, 115975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7614920</ArticleId><ArticleId IdType="pubmed">37301110</ArticleId></ArticleIdList></Reference><Reference><Citation>Brüssow H, Brüssow L (2021) Clinical evidence that the pandemic from 1889 to 1891 commonly called the Russian flu might have been an earlier coronavirus pandemic. Microbial Biotechnology 14(5), 1860–1870.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8441924</ArticleId><ArticleId IdType="pubmed">34254725</ArticleId></ArticleIdList></Reference><Reference><Citation>Saglanmak N, et al. (2011) Gradual changes in the age distribution of excess deaths in the years following the 1918 influenza pandemic in Copenhagen: using epidemiological evidence to detect antigenic drift. Vaccine 29, B42–B48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3144399</ArticleId><ArticleId IdType="pubmed">21757103</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>